Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy

アクセス数 : 666
ダウンロード数 : 222

今月のアクセス数 : 1
今月のダウンロード数 : 4
File
k7872_1.pdf 161 KB 種類 : abstract
File
k7872_2.pdf 177 KB 種類 : abstract
File
k7872_3.pdf 1.43 MB 種類 : fulltext
Title ( eng )
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy
Title ( jpn )
HAICとソラフェニブで治療した進行肝細胞癌の予後不良症例の予測に治療4週後の血清HMGB1濃度が有用である
Creator
Masuda Kazuhiko
Language
eng
Resource Type doctoral thesis
Rights
(c) The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Publish Type Not Applicable (or Unknown)
Access Rights open access
Source Identifier
Masuda, K., Ono, A., Aikata, H. et al. J Gastroenterol (2018) 53: 107.
[DOI] https://doi.org/10.1007/s00535-017-1348-8
Dissertation Number 甲第7872号
Degree Name
Date of Granted 2019-03-23
Degree Grantors
広島大学